Mark Menendez
Podiatrist · Lewes, DENPI 1619903556
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,137 of the $1,711 with a category attached, or 66.5%. Treace Medical Concepts, Inc. accounts for 84.2% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $1,366 and has fallen 97.8% since, to $30 in 2025.
Across 22 payments — averaging $77.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$1K
- Smith+Nephew$176
- Axogen$22
- Supreme Orthopedic Systems, LLC$22
- Bioventus LLC$21
- Biotissue Holdings Inc.$16
- plus $13 from 1 others
What the payments were for
- Travel & lodging$1,13766%
- Food & beverage$57434%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 14 | $1,442 |
| Smith+Nephew | 3 | $176 |
| Axogen | 1 | $22 |
| Supreme Orthopedic Systems, LLC | 1 | $22 |
| Bioventus LLC | 1 | $21 |
| Biotissue Holdings Inc. | 1 | $16 |
| Alfasigma USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$1,187
- EVOS$143
- TRIGEN InterTAN$143
How this compares
$1,711 in reported general payments places this provider in the 55th percentile of 37 podiatrist providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 13 | $11,473 |
| Gabapentin | 137 | $2,302 |
| Ciclopirox | 83 | $2,094 |
| Mupirocin | 104 | $779 |
| Celecoxib | 23 | $778 |
| Minocycline Hcl | 26 | $683 |
| Ciprofloxacin Hcl | 15 | $588 |
| Meloxicam | 201 | $567 |
| Ketoconazole | 24 | $527 |
| Imiquimod | 20 | $515 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 38 | $457 |
| Ammonium Lactate | 25 | $315 |
| Methylprednisolone | 48 | $313 |
| Pregabalin | 13 | $284 |
| Colchicine | 19 | $248 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Lewes
- Joseph WendolowskiLewes$5K
- Kathyrn LightcapLewes$919
- Andrew CollinsLewes$159
- Jennifer SeifertNewark$12K
- Harold GruberWilmington$10K
- Lahari MadulapallyWilmington$9K
- Jason KlineNewark$9K
- Matthew WaxmanMiddletown$7K
- Brian McDermottWilmington$7K
- Dimitrios MoustakasSmyrna$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.